List of Avidity Biosciences patents

Patents where

Current Assignee

Name

Avidity Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof	Patent 11834510 was granted and assigned to Avidity Biosciences on December, 2023 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11834510	December 5, 2023
‌ US Patent 10550188 Nucleic acid-polypeptide compositions and uses thereof	Patent 10550188 was granted and assigned to Avidity Biosciences on February, 2020 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10550188	February 4, 2020
‌ US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy	Patent 11912779 was granted and assigned to Avidity Biosciences on February, 2024 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11912779	February 27, 2024
‌ US Patent 10881743 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 10881743 was granted and assigned to Avidity Biosciences on January, 2021 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10881743	January 5, 2021
‌ US Patent 11179472 Nucleic acid-polypeptide compositions and methods of inducing exon skipping	Patent 11179472 was granted and assigned to Avidity Biosciences on November, 2021 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11179472	November 23, 2021
‌ US Patent 10487149 Nucleic acid-polypeptide compositions and uses thereof	Patent 10487149 was granted and assigned to Avidity Biosciences on November, 2019 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10487149	November 26, 2019
‌ US Patent 11028179 Anti-transferrin receptor antibodies and uses thereof	Patent 11028179 was granted and assigned to Avidity Biosciences on June, 2021 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11028179	June 8, 2021
‌ US Patent 10913800 Anti-transferrin receptor antibodies and uses thereof	Patent 10913800 was granted and assigned to Avidity Biosciences on February, 2021 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10913800	February 9, 2021
‌ US Patent 10994020 Nucleic acid-polypeptide compositions and methods of inducing exon skipping	Patent 10994020 was granted and assigned to Avidity Biosciences on May, 2021 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10994020	May 4, 2021
‌ US Patent 11400163 Nucleic acid-polypeptide compositions and methods of inducing exon skipping	Patent 11400163 was granted and assigned to Avidity Biosciences on August, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11400163	August 2, 2022
‌ US Patent 11311627 Nucleic acid-polypeptide compositions and methods of inducing exon skipping	Patent 11311627 was granted and assigned to Avidity Biosciences on April, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11311627	April 26, 2022
‌ US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy	Patent 11525137 was granted and assigned to Avidity Biosciences on December, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11525137	December 13, 2022
‌ US Patent 11578090 Nucleic acid-polypeptide compositions and uses thereof		Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11578090	February 14, 2023
‌ US Patent 11364302 Nucleic acid-polypeptide compositions and uses thereof	Patent 11364302 was granted and assigned to Avidity Biosciences on June, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11364302	June 21, 2022
‌ US Patent 11555190 Compositions and methods of treating Facioscapulohumeral muscular dystrophy	Patent 11555190 was granted and assigned to Avidity Biosciences on January, 2023 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11555190	January 17, 2023
‌ US Patent 11246941 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 11246941 was granted and assigned to Avidity Biosciences on February, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11246941	February 15, 2022
‌ US Patent 11253607 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 11253607 was granted and assigned to Avidity Biosciences on February, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11253607	February 22, 2022
‌ US Patent 10787519 Nucleic acid-polypeptide compositions and uses thereof	Patent 10787519 was granted and assigned to Avidity Biosciences on September, 2020 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10787519	September 29, 2020
‌ US Patent 11497814 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 11497814 was granted and assigned to Avidity Biosciences on November, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11497814	November 15, 2022
‌ US Patent 11576980 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 11576980 was granted and assigned to Avidity Biosciences on February, 2023 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11576980	February 14, 2023
‌ US Patent 11446387 Compositions and methods of treating muscle dystrophy	Patent 11446387 was granted and assigned to Avidity Biosciences on September, 2022 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11446387	September 20, 2022
‌ US Patent 11583591 Compositions and methods of treating muscle atrophy and myotonic dystrophy		Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11583591	February 21, 2023
‌ US Patent 11554176 Compositions and methods of treating muscle atrophy and myotonic dystrophy	Patent 11554176 was granted and assigned to Avidity Biosciences on January, 2023 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	11554176	January 17, 2023
‌ US Patent 10800848 Nucleic acid-polypeptide compositions and uses thereof	Patent 10800848 was granted and assigned to Avidity Biosciences on October, 2020 by the United States Patent and Trademark Office.	Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10800848	October 13, 2020
‌ US Patent 10858656 KRAS nucleic acids and uses thereof		Avidity Biosciences	Avidity Biosciences	United States Patent and Trademark Office	10858656	December 8, 2020

Results per page:

36 results

0 selected

36 results

0 selected